title: [Kidney and bone update : the 5-year history and future of CKD-MBD. Bone fragility in the aged hemodialysis patients].
abstract: Osteoporosis, as well as renal osteodystrophy, is a skeletal disorder predisposing to an increased risk of fracture. Although some medications to CKD-MBD prevent fragility fracture, the incidence of the fracture will increase according to the aging of the patients on maintenance hemodialysis.
authors: Department of Metabolism, Endocrinology and Molecular Medicine, Osaka City University Graduate School of Medicine, Japan.
authors: Yasuo
authors: Y
authors: Imanishi
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D001851:Bone Diseases, Metabolic / Q000150:complications / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D002908:Chronic Disease; D012080:Chronic Kidney Disease-Mineral and Bone Disorder / Q000209:etiology; D000069449:Cinacalcet; D004164:Diphosphonates / Q000627:therapeutic use; D005598:Fractures, Spontaneous / Q000209:etiology* / Q000517:prevention & control; D006706:Homeostasis; D006801:Humans; D007674:Kidney Diseases / Q000150:complications / Q000378:metabolism; D008903:Minerals / Q000378:metabolism; D009281:Naphthalenes / Q000627:therapeutic use; D010024:Osteoporosis / Q000209:etiology; D010758:Phosphorus / Q000378:metabolism; D006435:Renal Dialysis / Q000009:adverse effects*; D012306:Risk
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D008903:Minerals; D009281:Naphthalenes; D010758:Phosphorus; D002118:Calcium; D000069449:Cinacalcet